Share this Post!

Please be informed, that the CDRR is soliciting for comments from the concerned stakeholders on the draft FDA Circular entitled:  Interim Guidelines for the Issuance of Current Good Manufacturing Practice (cGMP) Clearance to Foreign Drug Manufacturers

Comments may be submitted by email to: [email protected] not later than 10 June 2020 (Wednesday) at 3:00PM using the following format:

Name of Company/Organization:
Contact information
Telephone number: Email address:
Section Comments Input/Recommendation/
Suggested text (if any)

In sending your comments, please use the subject: [Comments] Interim Guidelines for FcGMP Clearance

Thank you.

Attachment:->Announcement Interim Guidelines for the Issuance of Foreign cGMP Clearance

Attachment:->Draft on Interim Guidelines for the Issuance of Foreign cGMP Clearance